Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database

Wu,Wen‑Juan; Shen,Yang; Sui,Jing; Li,Cheng‑Yun; Yang,Sheng; Xu,Si‑Yi; Zhang,Man; Yin,Li‑Hong; Pu,Yue‑Pu; Liang,Ge‑Yu

doi:10.3892/mmr.2018.8846

Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database

Authors:
- Wen‑Juan Wu
- Yang Shen
- Jing Sui
- Cheng‑Yun Li
- Sheng Yang
- Si‑Yi Xu
- Man Zhang
- Li‑Hong Yin
- Yue‑Pu Pu
- Ge‑Yu Liang
View Affiliations

Affiliations: Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, P.R. China, Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China, Department of Medical Insurance, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, P.R. China
Published online on: April 5, 2018 https://doi.org/10.3892/mmr.2018.8846
Pages: 7845-7858

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer (CC) is a common gynecological malignancy in women worldwide. Using an RNA sequencing profile from The Cancer Genome Atlas (TCGA) and the CC patient information, the aim of the present study was to identify potential long non‑coding RNA (lncRNA) biomarkers of CC using bioinformatics analysis and building a competing endogenous RNA (ceRNA) co‑expression network. Results indicated several CC‑specific lncRNAs, which were associated with CC clinical information and selected some of them for validation and evaluated their diagnostic values. Bioinformatics analysis identified 51 CC‑specific lncRNAs (fold‑change >2 and P<0.05), and 42 of these were included in ceRNA network consisting of lncRNA‑miRNA‑mRNA interactions. Further analyses revealed that differential expression levels of 19 lncRNAs were significantly associated with different clinical features (P<0.05). A total of 11 key lncRNAs in the ceRNA network for reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis to detect their expression levels in 31 pairs of CC clinical samples. The results indicated that 7 lncRNAs were upregulated and 4 lncRNAs were downregulated in CC patients. The fold‑changes between the RT‑qPCR experiments and the TCGA bioinformatics analyses were the same. Furthermore, the area under the receiver operating characteristic (ROC) curve of four lncRNAs (EMX20S, MEG3, SYS1‑DBNDD2 and MIR9‑3HG) indicated that their combined use may have a significant diagnostic value in CC (P<0.05). To the best of our knowledge, the present study is the first to have identified CC‑specific lncRNAs to construct a ceRNA network and has also provided new insights for further investigation of a lncRNA‑associated ceRNA network in CC. In additon, the verification results suggested that the method of bioinformatics analysis and screening of lncRNAs was accurate and reliable. To conclude, the use of multiple lncRNAs may thus improve diagnostic efficacy in CC. In addition, these specific lncRNAs may serve as new candidate biomarkers for clinical diagnosis, classification and prognosis of CC.

View Figures

View References

1	Sankaranarayanan R and Ferlay J: Worldwide burden of gynaecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol. 20:207–225. 2006. View Article : Google Scholar : PubMed/NCBI
2	Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim SW and Kim YT: Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol. 46:521–530. 2015. View Article : Google Scholar : PubMed/NCBI
3	Bray F, Ren JS, Masuyer E and Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
4	O'Mara TA, Zhao M and Spurdle AB: Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome. Sci Rep. 6:366772016. View Article : Google Scholar : PubMed/NCBI
5	Dey BK, Mueller AC and Dutta A: Long non-coding RNAs as emerging regulators of differentiation, development and disease. Transcription. 5:e9440142014. View Article : Google Scholar : PubMed/NCBI
6	Mercer TR and Mattick JS: Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
7	Peng L, Yuan XQ, Liu ZY, Li WL, Zhang CY, Zhang YQ, Pan X, Chen J, Li YH and Li GC: High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers. Oncotarget. 8:1655–1667. 2017.PubMed/NCBI
8	Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Clin Transl Oncol. 19:162–172. 2017. View Article : Google Scholar : PubMed/NCBI
9	Liu J, Liu L, Wan JX and Song Y: Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/β-catenin signaling pathway. Oncotarget. 8:80700–80708. 2017.PubMed/NCBI
10	Peng Z, Wang J, Shan B, Yuan F, Li B, Dong Y, Peng W, Shi W, Cheng Y, Gao Y, et al: Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma. Sci Rep. 7:153312017. View Article : Google Scholar : PubMed/NCBI
11	Fu Y, Biglia N, Wang Z, Shen Y, Risch HA, Lu L, Canuto EM, Jia W, Katsaros D and Yu H: Long non-coding RNAs, ASAP1-IT1, FAM215A and LINC00472, in epithelial ovarian cancer. Gynecol Oncol. 143:642–649. 2016. View Article : Google Scholar : PubMed/NCBI
12	Sun R, Qin C, Jiang B, Fang S, Pan X, Peng L, Liu Z, Li W, Li Y and Li G: Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Mol Biosyst. 12:952–962. 2016. View Article : Google Scholar : PubMed/NCBI
13	Li Z, Chen Y, Hu S, Zhang J, Wu J, Ren W, Shao N and Ying X: Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Oncotarget. 7:82671–82685. 2016.PubMed/NCBI
14	Song X, Cao G, Jing L, Lin S, Wang X, Zhang J, Wang M, Liu W and Lv C: Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med. 18:991–1003. 2014. View Article : Google Scholar : PubMed/NCBI
15	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
16	Martin CM, Astbury K, Mcevoy L, O'Toole S, Sheils O and O'Leary JJ: Gene expression profiling in cervical cancer: Identification of novel markers for disease diagnosis and therapy. Methods Mol Biol. 511:333–359. 2009. View Article : Google Scholar : PubMed/NCBI
17	Goldfeder RL, Wall DP, Khoury MJ, Ioannidis JPA and Ashley EA: Human genome sequencing at the population scale: A primer on high-throughput DNA sequencing and analysis. Am J Epidemiol. 186:1000–1009. 2017. View Article : Google Scholar : PubMed/NCBI
18	Shukla HD: Comprehensive analysis of cancer-proteogenome to identify biomarkers for the early diagnosis and prognosis of cancer. Proteomes. 5:E282017. View Article : Google Scholar : PubMed/NCBI
19	Li S, Chen X, Liu X, Yu Y, Pan H, Haak R, Schmidt J, Ziebolz D and Schmalz G: Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncol. 73:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
20	Guo LL, Song CH, Wang P, Dai LP, Zhang JY and Wang KJ: Competing endogenous RNA networks and gastric cancer. World J Gastroenterol. 21:11680–11687. 2015. View Article : Google Scholar : PubMed/NCBI
21	Lu H, Shi B, Wu G, Zhang Y, Zhu X, Zhang Z, Liu C, Zhao Y, Wu T, Wang J and Chen R: Integrated analysis of multiple data sources reveals modular structure of biological networks. Biochem Biophys Res Commun. 345:302–309. 2006. View Article : Google Scholar : PubMed/NCBI
22	Zheng Y, Wei L, Guo L and Yang X: The expression level of miR-203 in patients with gastric cancer and its clinical significance. Pathol Res Pract. 13:1515–1518. 2017. View Article : Google Scholar
23	Miao Y, Xu SY, Chen LS, Liang GY, Pu YPG and Yin LH: Trends of long noncoding RNA research from 2007 to 2016: A bibliometric analysis. Oncotarget. 8:83114–83127. 2017. View Article : Google Scholar : PubMed/NCBI
24	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
25	World Health Organization (WHO): New WHO guide to prevent and control cervical cancer. http://www.who.int/mediacentre/news/releases/2014/preventing-cervical-cancer/en/December 3–2014
26	Moran VA, Perera RJ and Khalil AM: Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
27	Hu X, Sood AK, Dang CV and Zhang L: The role of long noncoding RNAs in cancer: The dark matter matters. Curr Opin Genet Dev. 48:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
28	Yang L, Yi K, Wang H, Zhao Y and Xi M: Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines. Oncotarget. 7:49917–49929. 2016.PubMed/NCBI
29	Wei G: Bioinformatics analysis of microRNA comprehensive regulatory network in congenital microtia. Int J Pediatr Otorhinolaryngol. 79:1727–1731. 2015. View Article : Google Scholar : PubMed/NCBI
30	Qu J, Li M, Zhong W and Hu C: Competing endogenous RNA in cancer: A new pattern of gene expression regulation. Int J Clin Exp Med. 8:17110–17116. 2015.PubMed/NCBI
31	Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
32	Thomson DW and Dinger ME: Endogenous microRNA sponges: Evidence and controversy. Nat Rev Genet. 17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
33	Karreth FA and Pandolfi PP: ceRNA cross-talk in cancer: When ce-bling rivalries go awry. Cancer Discov. 3:1113–11121. 2013. View Article : Google Scholar : PubMed/NCBI
34	Zhang L, Wu J, Ling MT, Zhao L and Zhao KN: The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 14:12015. View Article : Google Scholar : PubMed/NCBI
35	Zhang D, Sun G, Zhang H, Tian J and Li Y: Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 85:511–516. 2017. View Article : Google Scholar : PubMed/NCBI
36	Rong Z, Lu H, Lyu YY, Yang XM, Zhu LY, Yang GD, Jiang PC, Re Y, Song WW, Wang JH, et al: E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway. Sci Rep. 7:447442017. View Article : Google Scholar : PubMed/NCBI
37	Ling W, Zhigang H, Tian H, Bin Z, Xiaolin X and Hongxiu Z: HPV 16 infection up-regulates Piwil2, which affects cell proliferation and invasion in cervical cancer by regulating MMP-9 via the MAPK pathway. Eur J Gynaecol Oncol. 36:647–654. 2015.PubMed/NCBI
38	Wu Q, Guo L, Jiang F, Li L, Li Z and Chen F: Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER-breast cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015. View Article : Google Scholar : PubMed/NCBI
39	Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer. Int J Oncol. 48:1965–1976. 2016. View Article : Google Scholar : PubMed/NCBI
40	He JH, Han ZP, Liu JM, Zhou JB, Zou MX, Lv YB, Li YG and Cao MR: Overexpression of long non-coding RNA MEG3 inhibits proliferation of hepatocellular carcinoma Huh7 cells via negative modulation of miRNA-664. J Cell Biochem. 118:3713–3721. 2015. View Article : Google Scholar
41	Tong GF, Qin N, Sun LW and Xu XL: Long Noncoding RNA MEG3 suppresses glioma cell proliferation, migration and invasion by acting as competing endogenous RNA of MiR-19a. Oncol Res. 25:1471–1478. 2017. View Article : Google Scholar : PubMed/NCBI
42	Liao M, Li B, Zhang S, Liu Q, Liao W, Xie W and Zhang Y: Relationship between LINC00341 expression and cancer prognosis. Oncotarget. 8:15283–15293. 2017. View Article : Google Scholar : PubMed/NCBI
43	Bozgeyik E, Igci YZ, Jacksi MF, Arman K, Gurses SA, Bozgeyik I, Pala E, Yumrutas O, Temiz E and Igci M: A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples. Tumor Biol. 37:8791–8798. 2016. View Article : Google Scholar
44	Liu F, Yuan JH, Huang JF, Yang F, Wang TT, Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016. View Article : Google Scholar : PubMed/NCBI
45	Montpetit A, Larose J, Boily G, Langlois S, Trudel N and Sinnett D: Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia. 18:1499–1504. 2004. View Article : Google Scholar : PubMed/NCBI
46	Tian Z, Wen S, Zhang Y, Shi X, Zhu Y, Xu Y, Lv H and Wang G: Identification of dysregulated long non-coding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma. Oncotarget. 8:51703–51718. 2017. View Article : Google Scholar : PubMed/NCBI